ArticleiScience2025
SARS-CoV-2 nonstructural protein 1 suppresses host transcription by reducing RNA polymerase II levels.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has caused devastating global losses and massive mortality. The nonstructural protein 1 (NSP1) of SARS-CoV-2 plays a vital role in suppressing host protein synthesis. However, its effect on host gene transcription remains uncertain. We established a reporter system that enables the isolation of NSP1-overexpressing cells and confirmed that NSP1 leads to a global reduction in host mRNA levels, including those of common housekeeping genes. To accurately quantify transcriptomic changes in total and nascent RNA, we developed a pipeline integrating thio-labeled RNA sequencing (SLAM-seq) with External RNA Controls Consortium (ERCC) spike-in RNA normalization. Our research revealed a widespread downregulation of host mRNAs upon NSP1 expression, with virtually no genes significantly upregulated. Normalizing nascent RNA with ERCC spike-ins illustrated that NSP1 obstructed transcription by reducing RNA polymerase II levels. This study establishes a robust framework for investigating NSP1 and viral factors, providing insights into coronavirus-host interactions and potential therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.